Galecto, Inc. (GLTO)
NASDAQ: GLTO · Real-Time Price · USD
25.26
+2.63 (11.62%)
At close: Feb 6, 2026, 4:00 PM EST
25.32
+0.06 (0.24%)
After-hours: Feb 6, 2026, 7:06 PM EST
Galecto Market Cap
Galecto has a market cap or net worth of $40.35 million as of February 6, 2026. Its market cap has increased by 457.03% in one year.
Market Cap
40.35M
Enterprise Value
32.81M
1-Year Change
457.03%
Ranking
Category
Stock Price
$25.26
Market Cap Chart
Since the IPO on October 29, 2020, Galecto's market cap has decreased from $368.78M to $40.35M, a decrease of -89.06%. That is a compound annual growth rate of -34.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 40.35M | 9.78% |
| Dec 31, 2025 | 36.75M | 500.17% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| INmune Bio | 40.41M |
| PDS Biotechnology | 39.95M |
| Telomir Pharmaceuticals | 39.88M |
| Lite Strategy | 38.98M |
| Liminatus Pharma | 38.70M |
| Jasper Therapeutics | 38.62M |
| Generation Bio Co. | 37.93M |
| Anebulo Pharmaceuticals | 37.23M |